These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 10383167)
1. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Celis JE; Celis P; Ostergaard M; Basse B; Lauridsen JB; Ratz G; Rasmussen HH; Orntoft TF; Hein B; Wolf H; Celis A Cancer Res; 1999 Jun; 59(12):3003-9. PubMed ID: 10383167 [TBL] [Abstract][Full Text] [Related]
2. Proteomic strategies in bladder cancer. Celis JE; Wolf H; Ostergaard M IUBMB Life; 1999 Jul; 48(1):19-23. PubMed ID: 10791911 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Guo CC; Fine SW; Epstein JI Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332 [TBL] [Abstract][Full Text] [Related]
4. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related]
5. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Ostergaard M; Rasmussen HH; Nielsen HV; Vorum H; Orntoft TF; Wolf H; Celis JE Cancer Res; 1997 Sep; 57(18):4111-7. PubMed ID: 9307301 [TBL] [Abstract][Full Text] [Related]
6. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. Celis JE; Rasmussen HH; Vorum H; Madsen P; Honoré B; Wolf H; Orntoft TF J Urol; 1996 Jun; 155(6):2105-12. PubMed ID: 8618345 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of keratin proteins in urinary bladder carcinoma. Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Fukui S; Mori M Pathol Res Pract; 1989 Feb; 184(2):194-201. PubMed ID: 2469067 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive protein resource for the study of bladder cancer: http://biobase.dk/cgi-bin/celis. Celis JE; Ostergaard M; Rasmussen HH; Gromov P; Gromova I; Varmark H; Palsdottir H; Magnusson N; Andersen I; Basse B; Lauridsen JB; Ratz G; Wolf H; Orntoft TF; Celis P; Celis A Electrophoresis; 1999 Feb; 20(2):300-9. PubMed ID: 10197437 [TBL] [Abstract][Full Text] [Related]
9. Bladder squamous cell carcinoma biomarkers derived from proteomics. Celis JE; Wolf H; Ostergaard M Electrophoresis; 2000 Jun; 21(11):2115-21. PubMed ID: 10892722 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
11. Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression. Herman CJ; Vegt PD; Debruyne FM; Vooijs GP; Ramaekers FC Am J Pathol; 1985 Sep; 120(3):419-26. PubMed ID: 2412446 [TBL] [Abstract][Full Text] [Related]
12. [Cytokeratins and transitional epithelium of the bladder. Particular distribution of cytokeratins]. Fetissof F; Serres G; Haillot O Arch Anat Cytol Pathol; 1990; 38(4):159-62. PubMed ID: 1699500 [TBL] [Abstract][Full Text] [Related]
13. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Fong A; Garcia E; Gwynn L; Lisanti MP; Fazzari MJ; Li M Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378 [TBL] [Abstract][Full Text] [Related]
14. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018 [TBL] [Abstract][Full Text] [Related]
15. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818 [TBL] [Abstract][Full Text] [Related]
16. Detection of non-papillary, non-invasive transitional cell G1 carcinoma as revealed by increased DNA instability and other cancer markers. Hirose M; Sun A; Okubo T; Noriki S; Imamura Y; Fukuda M Eur J Histochem; 2005; 49(2):199-209. PubMed ID: 15967748 [TBL] [Abstract][Full Text] [Related]
17. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653 [TBL] [Abstract][Full Text] [Related]
18. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122 [TBL] [Abstract][Full Text] [Related]
19. Differentiation-dependent localisation of tissue-type plasminogen activator in human bladder urothelium. Makuc J; Masera A; Trsinar B; Jezernik K Cell Biol Int; 2004; 28(5):381-6. PubMed ID: 15193281 [TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue. Feil G; Maurer S; Nagele U; Krug J; Bock C; Sievert KD; Stenzl A Eur Urol; 2008 May; 53(5):1066-72. PubMed ID: 17980954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]